Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |